Paper20013699
[Leptin serum levels in cachectic and non-cachectic lung cancer patients].
Weryńska B and 3 others. Pneumonol Alergol Pol, 2009. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. [Leptin serum levels in cachectic and non-cachectic lung cancer patients]. Papers, record 20013699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20013699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cachexia | Major topic |
| Leptin | Major topic |
| Lung Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Biomarkers | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Nutritional Status | |
| Young Adult |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41373779 | Cancer-Associated Cachexia in the Era of Obesity. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373779 | PubMed |
| 40298389 | Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies. | Cancer Discov | 2025 | https://conductscience.org/library/papers/40298389 | PubMed |
| 35646636 | Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia. | Front Oncol | 2022 | https://conductscience.org/library/papers/35646636 | PubMed |
| 32584233 | Evaluation of Serum Resistin, Visfatin, and Chemerin Levels in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease. | Turk Thorac J | 2020 | https://conductscience.org/library/papers/32584233 | PubMed |
| 32321448 | A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes. | BMC Psychiatry | 2020 | https://conductscience.org/library/papers/32321448 | PubMed |
| 28160559 | Serum and tissue leptin in lung cancer: A meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28160559 | PubMed |
| 26508820 | Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia. | Mediators Inflamm | 2015 | https://conductscience.org/library/papers/26508820 | PubMed |
| 25400234 | Emerging markers of cachexia predict survival in cancer patients. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25400234 | PubMed |
| 24758911 | [Advances of the relationship between leptin system and non-small cell lung cancer]. | Zhongguo Fei Ai Za Zhi | 2014 | https://conductscience.org/library/papers/24758911 | PubMed |
| 22518191 | Leptin in anorexia and cachexia syndrome. | Int J Pept | 2012 | https://conductscience.org/library/papers/22518191 | PubMed |
| 22246553 | Adipokines and systemic inflammation in weight-losing lung cancer patients. | Lung | 2012 | https://conductscience.org/library/papers/22246553 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LEP | 3952 | PubTator's text mining | https://conductscience.org/library/genes/3952 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20013699
GET https://conductscience.org/api/papers/v1/20013699/authors